Discover the latest updates on the ongoing novel coronavirus outbreak in the ‘COVID-19 Hub’, powered by Infectious Diseases Hub and our partner journals and eCommunities across the Future Science Group family.
The COVID-19 outbreak has rapidly swept the world since first being reported in December 2019, leading to an ever-increasing number of cases and deaths, severe pressure on health services across the globe, and unprecedented restrictions on movement, transport, business and education.
Here, you can discover the latest news headlines and daily updates, and also read more in-depth articles on the pandemic collated from across the Future Science Group journals and eCommunities: all content is fully open-access and free to read, and will be updated daily.
Want to stay updated? Receive the latest news direct to your inbox by becoming a member: register for free here.
Latest coronavirus news – updated daily
News stories from this week:
- Membrane on a chip could be used to safely test COVID-19 drug candidates (The Nanomed Zone)
- Genetic variant puts African-American populations at greater risk of hydroxychloroquine cardiac complications (BioTechniques)
- MMR vaccine could protect against complications of COVID-19 (BioTechniques)
- Is the new strain of SARS-CoV-2 more infectious than the last? (ID Hub)
- SARS-CoV-2 can infect human myocardiocytes in vitro (ID Hub)
- Researchers identify inflammatory molecules as potential targets for COVID-19 (ID Hub)
- FDA joins multi-stakeholder effort to leverage real-world data in COVID-19 diagnostic testing space (The Evidence Base)
- New registry to aid understanding of new-onset diabetes associated with COVID-19 (The Evidice Base)
- COVID-19 and rheumatic diseases: what factors may affect odds of hospitalization? (The Evidence Base)
- Nanosponges could absorb SARS-CoV-2 virus (The Nanomed Zone)
- Highly potent human antibodies neutralize COVID-19 in animal tests (ID Hub)
- Patients with severe COVID-19 may benefit from dexamethasone treatment (ID Hub)
- News updates: nano-based vaccines for treatment of COVID-19 (The Nanomed Zone)
- Nearly half of all SARS-CoV-2 infections may be asymptomatic (ID Hub)
- Adaptive immune responses to SARS-CoV-2 differ with HLA genetic variation (ID Hub)
- Researchers repurpose cancer immunotherapy tools for COVID-19 vaccine research (ID Hub)
- 3D printing in a time of coronavirus: the additive response to COVID-19 (3DMedNet)
- Convalescent plasma therapy improves outcomes for majority of COVID-19 patients in study (ID Hub)
- Why are Black people more likely to die of COVID-19 in the US and UK? (BioTechniques)
- COVID-19 lockdown has significantly improved air quality in China (BioTechniques)
- False negatives: how accurate are PCR tests for COVID-19? (BioTechniques)
- Exploring the neurological symptoms of COVID-19 (Neuro Central)
- Can remdesivir treatment improve recovery time for COVID-19 patients? (ID Hub)
- First human COVID-19 vaccine trial displays promising results (ID Hub)
- COVID-19: vaccine and drug development updates (BioTechniques)
- Alzheimer’s risk gene may increase risk of developing severe COVID-19 (Neuro Central)
- Primate studies offer hope for future COVID-19 vaccine development (ID Hub)
- Neutralizing SARS antibody also blocks related coronaviruses (ID Hub)
- Nanotech gives detailed risk assessment of COVID-19 patients (The Nanomed Zone)
- News updates: nano-based vaccines for treatment of COVID-19 (The Nanomed Zone)
- Using computer models to outsmart spike proteins in SARS-CoV-2 (BioTechniques)
- Collaboration is key: experts suggest a coordinated strategy is essential for COVID-19 vaccine development (BioTechniques)
- Diagnosing COVID-19 without a test (BioTechniques)
- FDA research collaboration to use real-world data to help study COVID-19 (The Evidence Base)
- Smoking linked to increased expression of SARS-CoV-2 receptor (ID Hub)
- Treatment with interferon-α-2b could speed COVID-19 recovery (ID Hub)
- Nanoparticle coating could kill viruses present on surfaces (The Nanomed Zone)
- MicroRNAs attacking SARS-CoV-2 diminish with age and chronic health problems (ID Hub)
- Two registries will help further understanding of cardiac impacts of COVID-19 (The Evidence Base)
- Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA (Bioanalysis Zone)
- Novel vaccine platform for MERS could be applicable to COVID-19 (ID Hub)
- Blood test could be new tool for infectious disease surveillance (Bioanalysis Zone)
- Mologic and BioSure partner to produce antibody self-test for COVID-19 (Bioanalysis Zone)
- Prostate cancer treatment could protect men from COVID-19 (Oncology Central)
- Could a symptom tracker app prevent future COVID-19 outbreaks? (ID Hub)
- Researchers discover antibody that prevents SARS-CoV-2 from infecting cells (ID Hub)
- Scepticism grows over use of hydroxychloroquine for COVID-19 (ID Hub)
- Predicting the course of a pandemic: when will COVID-19 end? (BioTechniques)
- Improving access to expression platforms for COVID-19 (BioTechniques)
- Low T cell counts could affect outcomes for COVID-19 patients (ID Hub)
- Analysis of coronavirus tracing data provides key insights into its spread (ID Hub)
- News updates: nano-based diagnostics for COVID-19 (The Nanomed Zone)
- Gold-coated nanovesicles for drug delivery applied to rapid COVID-19 testing (The Nanomed Zone)
- Treating COVID-19 in cancer patients (BioTechniques)
- Global collaboration provides guidance on how to manage cancer patients with COVID-19 (Oncology Central)
- High survival rates in trial against severe COVID-19–related respiratory distress (RegMedNet)
- New collaboration strives for better understanding of cellular mechanisms of COVID-19 (Bioanalysis Zone)
- Serological test developed for COVID-19 (Bioanalysis Zone)
- Which cell types are infected by SARS-CoV-2? (ID Hub)
- MSCs demonstrate promise against COVID-19–related respiratory distress (RegMedNet)
- SARS-CoV-2 testing: a roundup of novel PCR developments (BioTechniques)
- International collaboration to develop one-step PCR test for COVID-19 (Bioanalysis Zone)
- Test for SARS-CoV-2 joins arsenal of assays granted emergency use authorization (Bioanalysis Zone)
- Drug repurposing study uses live virus to identify 30 potential COVID-19 candidates (ID Hub)
- COVID-19 and SARS-CoV-2: the latest news (BioTechniques)
- Modified proteins could help weather the storm of coronavirus (BioTechniques)
- SARS-CoV-2 detected in nasopharyngeal swabs by biosensor (The Nanomed Zone)
- COVID-19: Engineers awarded federal funding for fluorescence test (The Nanomed Zone)
- The journey to a COVID-19 vaccine (ID Hub)
- Using computer models to outsmart spike proteins in SARS-CoV-2 (The Nanomed Zone)
- Countries with aging populations are most at risk of high COVID-19 death rate (BioTechniques)
- A new test to detect viral DNA in COVID-19 patients (The Nanomed Zone)
- International NETwork investigates the role of neutrophils in severe COVID-19 cases (ID Hub)
- Does COVID-19 pose a greater risk to individuals with diabetes? (BioTechniques)
- How to (not) sniff out COVID-19 (ID Hub)
- COVID-19 and SARS-CoV-2: new research, vaccine and drug development news (BioTechniques)
- Coronavirus culprit: spike proteins disabled by peptide drugs (The Nanomed Zone)
- COVID-19: are exposed individuals at a heightened risk of neuropsychiatric symptoms? (Neuro Central)
- COVID-19 saliva test from Rutgers granted emergency use authorization by FDA (Bioanalysis Zone)
- Database tracks over 200 clinical trials testing drugs against COVID-19 (ID Hub)
- Protecting user privacy on COVID-19 contact-tracing apps: eight essential considerations (The Evidence Base)
- Life sciences companies enter international partnership to develop and manufacture rapid test for COVID-19 (Bioanalysis Zone)
- MERS vaccine success in mice suggests potential for COVID-19 vaccine development (ID Hub)
- From bats to big cats: how are animals affected by COVID-19? (BioTechniques)
- COVID-19: experts suggest updated treatment guidelines for bowel cancer (Oncology Central)
- Insight into SARS-CoV-2 genome spells good news for vaccine development (BioTechniques
- Trial drug against COVID-19 shows promise in engineered human tissues (ID Hub)
- Could tocilizumab reduce COVID-19 symptoms for blood cancer patients? (Oncology Central)
- COVID-19 vaccine candidate shows promise in preclinical research (ID Hub)
- Man’s best friend to the rescue! Dogs could be taught to ‘sniff out’ coronavirus (BioTechniques)
- COVID-19: how can we prevent SARS-CoV-2 infection in cancer patients? (Oncology Central)
- International community generating real-world evidence on COVID-19 (The Evidence Base)
- Studies to investigate protective effects of hydroxychloroquine against COVID-19 for healthcare workers (The Evidence Base)
- Thousands of coronavirus cases prevented by China’s control interventions, analysis suggests (ID Hub)
- COVID-19: latest news and updates (BioTechniques)
- Could artificial intelligence be the key to fighting coronavirus? (BioTechniques)
- New registry launched to collect and share data on how COVID-19 affects individuals with rheumatic diseases (The Evidence Base)
- Improved COVID-19 symptom-tracking app recruiting users across the USA (The Evidence Base)
- Pangolins: the missing link in coronavirus transmission? (ID Hub)
- COVID-19 diagnostic test enters validation process (Bioanalysis Zone)
- COVID-19: do cancer patients have a higher risk of infection? (Oncology Central)
- Nanovaccines could provide the key to fighting today’s deadliest viruses (The Nanomed Zone)
- Real-time symptom-tracking app launched to curtail COVID-19 spread (The Evidence Base)
- FDA promotes expanded use of remote health monitoring devices, to limit in-person patient—provider contact during the COVID-19 outbreak (The Evidence Base)
- COVID-19 monitoring program launched by PRA Health Sciences (Bioanalysis Zone)
- Mobile health platform could improve clinical trial support during COVID-19 pandemic (Bioanalysis Zone)
- Coronavirus: continued updates in basic research, vaccine development and testing (BioTechniques)
- COVID-19 monitoring program launched by PRA Health Sciences (Bioanalysis Zone)
- ‘Highly Relevant’ cell therapy for acute corona-related respiratory distress (RegMedNet)
- COVID-19: borders and businesses close across Europe (ID Hub)
- Could a mobile app for contact tracing help in the fight against COVID-19? (The Evidence Base)
- COVID-19: First patients dosed in Phase I vaccine trial (ID Hub)
- Update: First patients dosed with COVID-19 nanovaccine in Phase 1 trial (The Nanomed Zone)
- Coronavirus: sorting the fact from the fiction (BioTechniques)
- Innovative nanofiber filter could be vital in the development of face masks and respirators (BioTechniques)
- 3D-printed valves supply unmanageable demand for essential ventilator equipment (3DMedNet)
- A unique solution for ‘containment’: Materialise releases minimum-contact door handle (3DMedNet)
- Collaborative teams solves PPE shortage issue: 3D-printed facemasks and screens for healthcare workers in Hong Kong (3DMedNet)
- When industries unite: how 3D-printed ‘huts’ serve as emergency quarantine wards (3DMedNet)
- FDA issue emergency use authorization to Thermo Fisher Scientific for COVID-19 diagnostic test (Bioanalysis Zone)
- US FDA grants further emergency use authorization for coronavirus assays, bringing total to four (Bioanalysis Zone)
- COVID-19 labelled as a pandemic by WHO (ID Hub)
- The race for COVID-19 treatments and vaccines: February’s industry headlines (ID Hub)
- 2019-nCoV related to SARS-like coronaviruses of bat origin (ID Hub)
- COVID-19: stricter measures introduced across the globe (ID Hub)
Longer reads and insights
- New single-molecule imaging technology could open a window into SARS-CoV-2 (BioTechniques)
- COVID-19 research round-up: June (ID Hub)
- Confronting COVID-19 head on at the Wyss Institute (ID Hub)
- Adaptive study design and the potential of convalescent plasma therapy for COVID-19 – an interview with José Javier García (ID Hub)
- Self-amplifying RNA vaccine against COVID-19 (The Nanomed Zone)
- A peek behind the paper – Wenqing Jiang on the application of evolutionary theories to SARS-CoV-2 (ID Hub)
- A peek behind the paper – John Nemunaitis on targeting furin to tackle SARS-CoV-2 (ID Hub)
- A closer look at the COVID-19 vaccine front-runners (ID Hub)
- COVID-19 and cell therapy: an interview with Daniel Weiss (RegMedNet)
- Bioprinting 3D tissues for testing COVID-19 therapeutics: an interview with CLECELL (3DMedNet)
- COVID-19 retractions put the spotlight on bad data (BioTechniques)
- COVID-19: side effects of healthcare’s digitalization in England – harnessing the positives and mitigating the negatives (The Evidence Base)
- 3DMedTALKS | The additive response to COVID-19 (3DMedNet)
- COVID-19 research round-up: May (ID Hub)
- Does COVID-19 predispose patients to cancer? A peek behind the paper with Priya Hays (Oncology Central)
- A peek behind the paper: Suranga Senanayake on a potential avenue for COVID-19 therapeutic discovery (BioTechniques)
- Navigating the COVID-19 pandemic – a new way of living for people with multiple sclerosis? (Neuro Central)
- COVID-19 experts discuss exosomes and mesenchymal stem cells as experimental treatment for ARDS/COVID-19 (RegMedNet)
- Peek behind the paper: Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application (RegMedNet)
- The role of design, risk management and 3D printing during the COVID-19 pandemic (3DMedNet)
- COVID-19: regional perspectives from oncology centers in Lebanon, Syria, Iraq, Jordan and Turkey (Oncology Central)
- Pathogen biogeography: using a new model to predict disease outbreaks (ID Hub)
- Application of nanomaterials in treatment, anti-infection and detection of coronaviruses (Nanomed Zone)
- The impact of the COVID-19 pandemic on neurology: an insight from Gavin Giovannoni (Neuro Central)
- The COVID-19 pandemic and the research lab (Neuro Central)
- Ray Owens on nanobody technology for use against SARS-CoV-2 (Nanomed Zone)
- What do cancer patients want answered about COVID-19? (Oncology Central)
- COVID-19 research round-up: April (ID Hub)
- Hunting for a SARS-CoV-2 biomarker with metabolomics (BioTechniques)
- A peek behind the paper – Kamal Dua on miRNA nanotherapeutics: potential and challenges in respiratory disorders (Nanomed Zone)
- The potential impact of COVID-19 on cancer mortality in the UK (Oncology Central)
- Concerns surrounding safety in the 3D printing response to COVID-19 (3DMedNet)
- Responding to COVID-19 in the nursing home – an interview with Teena Chopra (ID Hub)
- Are cancer patients more vulnerable to severe outcomes of COVID-19? (BioTechniques)
- Utilizing real-world data to inform healthcare decision making during the COVID-19 pandemic: an interview with Daniel Prieto-Alhambra (The Evidence Base)
- COVID-19 and microsampling: from patient-centric testing to drug development and beyond (Bioanalysis Zone)
- The relevance of registry and real-world data during the COVID-19 pandemic: an interview with Philip Robinson (The Evidence Base)
- Top 10 articles on COVID-19 (ID Hub)
- COVID-19: How has the scientific community risen to the challenge? (BioTechniques)
- Refocusing our microbiome lab for SARS-CoV-2 research (BioTechniques)
- Highlights from the WHO press briefing on COVID-19 – 20 April 2020 (BioTechniques)
- Talking Techniques: Rob Vries on organoids for drug discovery and the study of COVID-19 (BioTechniques)
- Talking Techniques: Donald Ingber on COVID-19, organ-on-a-chip technology and the Wyss Institute (BioTechniques)
- Fighting coronavirus with MSCs: an interview with Ross Macdonald (RegMedNet)
- The economic impact of COVID-19 in Canada: a health economist’s perspective (ID Hub)
- Responding to COVID-19 with AI and machine learning (ID Hub)
- Coronavirus lockdown for bioanalysts: personal and professional challenges (Bioanalysis Zone)
- The effect of temperature fluctuations on the evolving coronavirus: speculations by Morteza Mahmoudi (The Nanomed Zone)
- ‘COVID Symptom Tracker’: an interview with SU2C CEO, Sung Poblete (Oncology Central)
- The importance of diagnostic testing for COVID-19 (ID Hub)
- Coronavirus: continued updates in basic research, vaccine development and testing (BioTechniques)
- COVID-19 vaccine developments (Bioanalysis Zone)
- COVID-19 is opening a door to a new era in drug development (Bioanalysis Zone)
- What role can the media play in managing the COVID-19 outbreak? (ID Hub)
- COVID-19: how the coronavirus spread globally (ID Hub)
- Eric Chen: imaging the atomic-resolution structure of coronavirus ‘spike’ protein (BioTechniques)
- COVID-19 testing: potential challenges and solutions (Bioanalysis Zone)
- The emergence and spread of the 2019 novel coronavirus (ID Hub)
- COVID-19 is opening a door to a new era in drug development (Bioanalysis Zone)
- On the (continued) hunt for a coronavirus vaccine (BioTechniques)
- COVID-19 low-cost and laboratory-safe detection protocol (Bioanalysis Zone)
- Coronavirus and bioanalysis: the fight against COVID-19 (Bioanalysis Zone)
- Emerging technologies to investigate coronavirus emergence – an interview with Vineet Menachery (ID Hub)
- From wildlife to humans with the PREDICT project – an interview with Tracey Goldstein (ID Hub)
- Assessing the epidemic threat of viruses – candidates for the next pandemic (ID Hub)
Articles from the Future Science Group journal collection
Journal highlights
- Sudden cardiac death in COVID-19 patients, a report of three cases
Shirazi et al., 2020 – Future Cardiology - COVID-19 in homeless populations: unique challenges and opportunities
Conway et al., 2020 – Future Virology - Vesicular drug-delivery systems as theranostics in COVID-19
Satija et al., 2020 – Future Medicinal Chemistry - Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists
Mrabti et al., 2020 – Future Oncology - Empowering academic labs and scientists to test for COVID-19
Steel et al., 2020 – Biotechniques - Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists
Mrabti et al., 2020 – Future Oncology - Empowering academic labs and scientists to test for COVID-19
Steel et al., 2020 – Biotechniques - Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience
Garrafa et al., 2020 – Bioanalysis - Tackling SARS-CoV-2: proposed targets and repurposed drugs
Joshi et al., 2020 – Future Medicinal Chemistry - Role of clinical laboratories in response to the COVID-19 pandemic
Sahajpal et al., 2020 – Future Medicinal Chemistry - Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19
Mandal and Panda, 2020 – Biotechniques - Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019
Melody et al., 2020 – Immunotherapy - Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor
Hu et al., 2020 – Future Virology - Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection
Tan et al., 2020 – Future Virology - COVID-19 and coronaviral hepatitis: evidence of collateral damage
Parvez MK, 2020 – Future Virology - Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
Moujaess et al., 2020 – Pharmacogenomics - Focus on a 2019-novel coronavirus (SARS-CoV-2)
Zhang et al., 2020 – Future Microbiology - Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations
Snyder and Johnson, 2020 – Pharmacogenomics - Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents
Ayaz and Crea, 2020 – Epigenomics - Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19
Li et al., 2020 – Biomarkers in Medicine - The future of cancer research after COVID-19 pandemic: recession?
Kourie et al., 2020 – Future Oncology - A suspected case of COVID-19 turned into a confirmed case: a case report from Iran
Yang et al., 2020 – Future Virology - Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?
Uskoković V, 2020 – Nanomedicine - Hematopoietic stem cell transplantation dilemma during the COVID-19 era
- Samaha and Kattan, 2020 – Future Oncology
- Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?
Hays P, 2020 – Future Oncology - Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2
Senanayake SL, 2020 – Future Drug Discovery - Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
Cheng and Li, 2020 – BioTechniques - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise
Nemunaitis et al., 2020 – Future Virology - Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond
Kar and Islam, 2020 – Bioanalysis - Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors
Salman et al., 2020 – Future Virology - Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
Fani et al., 2020 – Future Virology - Better preventing and mitigating the effects of COVID-19
Maguire G, 2020 – Future Science OA - Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis
Ielapi et al., 2020 – Biomarkers in Medicine - Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?
O’Connor et al., 2020 – Future Oncology - Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
Stroppa et al., 2020 – Future Oncology - Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
Freitag et al., 2020 – Future Science OA - Prediction and analysis of key protein structures of 2019-nCoV
Li et al., 2020 – Future Virology - COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics
Amawi et al., 2020 – Therapeutic Delivery - Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
Diez et al., 2020 – Immunotherapy - Life after COVID-19: R WE going to help?
Ramagopalan SV, 2020 – Journal of Comparative Effectiveness Research - Application of nanomaterials in treatment, anti-infection and detection of coronaviruses
Nikaeen et al., 2020 – Nanomedicine - The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification
Li et al., 2020 – Future Virology - Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2
Li et al., 2020 – Future Virology - Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic
Pravda et al., 2020 – Future Cardiology - Exhaled breath condensate as a potential specimen for diagnosing COVID-19
Khoubnasabjafari et al., 2020 – Bioanalysis - Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Bersanelli M, 2020 – Imunotherapy - Drug repurposing strategies for COVID-19
Senanayake SL, 2020 – Future Drug Discovery - Membrane binding proteins of coronaviruses
Alsaadi and Jones, 2019 – Future Virology - Verification and diagnostic evaluation of the RealStar® Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0
Hecht et al., 2019 – Future Microbiology - Engineering a novel endopeptidase based on SARS 3CLpro
Kuo et al., 2018 – BioTechniques - Post-translational modifications of coronavirus proteins: roles and function
Fung and Liu, 2018 – Future Virology
View the full collection of coronavirus-related journal articles here on BioTechniques – all articles are open access (page will be updated with all new articles as they are published)
Further resources
Patient-centric sampling – Bioanalysis Zone
Many of Future Science Group’s specialized eCommunities are covering the COVID-19 pandemic from a range of perspectives, including 3D printing, bioanalysis and mental health. Find out more and discover our eCommunities below:
- 3DMedNet
- Bioanalysis Zone
- BioTechniques
- Nanomed Zone
- Neuro Central
- Oncology Central
- RegMedNet
- The Evidence Base®
